IBDEI04C ; ; 09-MAY-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 09, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5524,1,3,0)
 ;;=3^J9035
 ;;^UTILITY(U,$J,358.3,5525,0)
 ;;=J2778^^35^390^5^^^^1
 ;;^UTILITY(U,$J,358.3,5525,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5525,1,2,0)
 ;;=2^Ranibizumab Inj per 0.1mg
 ;;^UTILITY(U,$J,358.3,5525,1,3,0)
 ;;=3^J2778
 ;;^UTILITY(U,$J,358.3,5526,0)
 ;;=J3301^^35^390^4^^^^1
 ;;^UTILITY(U,$J,358.3,5526,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5526,1,2,0)
 ;;=2^Kenalog Inj per 10mg
 ;;^UTILITY(U,$J,358.3,5526,1,3,0)
 ;;=3^J3301
 ;;^UTILITY(U,$J,358.3,5527,0)
 ;;=J0178^^35^390^2^^^^1
 ;;^UTILITY(U,$J,358.3,5527,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5527,1,2,0)
 ;;=2^Aflibercept Inj 1mg
 ;;^UTILITY(U,$J,358.3,5527,1,3,0)
 ;;=3^J0178
 ;;^UTILITY(U,$J,358.3,5528,0)
 ;;=4450F^^35^391^2^^^^1
 ;;^UTILITY(U,$J,358.3,5528,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5528,1,2,0)
 ;;=2^Self-Care Ed Provided to Pt
 ;;^UTILITY(U,$J,358.3,5528,1,3,0)
 ;;=3^4450F
 ;;^UTILITY(U,$J,358.3,5529,0)
 ;;=4177F^^35^391^3^^^^1
 ;;^UTILITY(U,$J,358.3,5529,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5529,1,2,0)
 ;;=2^Talk Pt/Crgvr Re AREDS
 ;;^UTILITY(U,$J,358.3,5529,1,3,0)
 ;;=3^4177F
 ;;^UTILITY(U,$J,358.3,5530,0)
 ;;=4174F^^35^391^1^^^^1
 ;;^UTILITY(U,$J,358.3,5530,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,5530,1,2,0)
 ;;=2^Couns Potent Glauc Impct
 ;;^UTILITY(U,$J,358.3,5530,1,3,0)
 ;;=3^4174F
 ;;^UTILITY(U,$J,358.3,5531,0)
 ;;=373.32^^36^392^48
 ;;^UTILITY(U,$J,358.3,5531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5531,1,3,0)
 ;;=3^Eyelid,Dermatitis,Allergic
 ;;^UTILITY(U,$J,358.3,5531,1,4,0)
 ;;=4^373.32
 ;;^UTILITY(U,$J,358.3,5531,2)
 ;;=^269061
 ;;^UTILITY(U,$J,358.3,5532,0)
 ;;=373.00^^36^392^4
 ;;^UTILITY(U,$J,358.3,5532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5532,1,3,0)
 ;;=3^Blepharitis
 ;;^UTILITY(U,$J,358.3,5532,1,4,0)
 ;;=4^373.00
 ;;^UTILITY(U,$J,358.3,5532,2)
 ;;=Blepharitis^15271
 ;;^UTILITY(U,$J,358.3,5533,0)
 ;;=373.2^^36^392^7
 ;;^UTILITY(U,$J,358.3,5533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5533,1,3,0)
 ;;=3^Chalazion
 ;;^UTILITY(U,$J,358.3,5533,1,4,0)
 ;;=4^373.2
 ;;^UTILITY(U,$J,358.3,5533,2)
 ;;=^22156
 ;;^UTILITY(U,$J,358.3,5534,0)
 ;;=374.84^^36^392^29
 ;;^UTILITY(U,$J,358.3,5534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5534,1,3,0)
 ;;=3^Eyelid Cysts
 ;;^UTILITY(U,$J,358.3,5534,1,4,0)
 ;;=4^374.84
 ;;^UTILITY(U,$J,358.3,5534,2)
 ;;=^269119
 ;;^UTILITY(U,$J,358.3,5535,0)
 ;;=374.87^^36^392^31
 ;;^UTILITY(U,$J,358.3,5535,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5535,1,3,0)
 ;;=3^Eyelid Dermatochalasis
 ;;^UTILITY(U,$J,358.3,5535,1,4,0)
 ;;=4^374.87
 ;;^UTILITY(U,$J,358.3,5535,2)
 ;;=^269123
 ;;^UTILITY(U,$J,358.3,5536,0)
 ;;=375.15^^36^392^12
 ;;^UTILITY(U,$J,358.3,5536,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5536,1,3,0)
 ;;=3^Dry Eye Syndrome
 ;;^UTILITY(U,$J,358.3,5536,1,4,0)
 ;;=4^375.15
 ;;^UTILITY(U,$J,358.3,5536,2)
 ;;=Dry Eye Syndrome^37168
 ;;^UTILITY(U,$J,358.3,5537,0)
 ;;=374.01^^36^392^20
 ;;^UTILITY(U,$J,358.3,5537,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5537,1,3,0)
 ;;=3^Entropion, Senile
 ;;^UTILITY(U,$J,358.3,5537,1,4,0)
 ;;=4^374.01
 ;;^UTILITY(U,$J,358.3,5537,2)
 ;;=Entropion, Senile^269074
 ;;^UTILITY(U,$J,358.3,5538,0)
 ;;=375.20^^36^392^68
 ;;^UTILITY(U,$J,358.3,5538,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5538,1,3,0)
 ;;=3^Lacrimal,Epiphora
 ;;^UTILITY(U,$J,358.3,5538,1,4,0)
 ;;=4^375.20
 ;;^UTILITY(U,$J,358.3,5538,2)
 ;;=Epiphora^269136
 ;;^UTILITY(U,$J,358.3,5539,0)
 ;;=373.11^^36^392^63
 ;;^UTILITY(U,$J,358.3,5539,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5539,1,3,0)
 ;;=3^Hordeolum Externum
 ;;^UTILITY(U,$J,358.3,5539,1,4,0)
 ;;=4^373.11
 ;;^UTILITY(U,$J,358.3,5539,2)
 ;;=^58510
 ;;^UTILITY(U,$J,358.3,5540,0)
 ;;=373.12^^36^392^64
 ;;^UTILITY(U,$J,358.3,5540,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5540,1,3,0)
 ;;=3^Hordeolum Internum
 ;;^UTILITY(U,$J,358.3,5540,1,4,0)
 ;;=4^373.12
 ;;^UTILITY(U,$J,358.3,5540,2)
 ;;=^58512
 ;;^UTILITY(U,$J,358.3,5541,0)
 ;;=216.1^^36^392^54
 ;;^UTILITY(U,$J,358.3,5541,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5541,1,3,0)
 ;;=3^Eyelid/Canthus,Benign Neopl
 ;;^UTILITY(U,$J,358.3,5541,1,4,0)
 ;;=4^216.1
 ;;^UTILITY(U,$J,358.3,5541,2)
 ;;=Neoplasm, Benign of Lid^267630
 ;;^UTILITY(U,$J,358.3,5542,0)
 ;;=374.30^^36^392^43
 ;;^UTILITY(U,$J,358.3,5542,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5542,1,3,0)
 ;;=3^Eyelid Ptosis,Unspec
 ;;^UTILITY(U,$J,358.3,5542,1,4,0)
 ;;=4^374.30
 ;;^UTILITY(U,$J,358.3,5542,2)
 ;;=^15283
 ;;^UTILITY(U,$J,358.3,5543,0)
 ;;=375.30^^36^392^9
 ;;^UTILITY(U,$J,358.3,5543,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5543,1,3,0)
 ;;=3^Dacryocystitis
 ;;^UTILITY(U,$J,358.3,5543,1,4,0)
 ;;=4^375.30
 ;;^UTILITY(U,$J,358.3,5543,2)
 ;;=Dacrocystitis^30880
 ;;^UTILITY(U,$J,358.3,5544,0)
 ;;=921.1^^36^392^28
 ;;^UTILITY(U,$J,358.3,5544,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5544,1,3,0)
 ;;=3^Eyelid Contusion
 ;;^UTILITY(U,$J,358.3,5544,1,4,0)
 ;;=4^921.1
 ;;^UTILITY(U,$J,358.3,5544,2)
 ;;=^275367
 ;;^UTILITY(U,$J,358.3,5545,0)
 ;;=374.51^^36^392^46
 ;;^UTILITY(U,$J,358.3,5545,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5545,1,3,0)
 ;;=3^Eyelid Xanthelasma
 ;;^UTILITY(U,$J,358.3,5545,1,4,0)
 ;;=4^374.51
 ;;^UTILITY(U,$J,358.3,5545,2)
 ;;=^269107
 ;;^UTILITY(U,$J,358.3,5546,0)
 ;;=374.11^^36^392^15
 ;;^UTILITY(U,$J,358.3,5546,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5546,1,3,0)
 ;;=3^Ectropion, Senile
 ;;^UTILITY(U,$J,358.3,5546,1,4,0)
 ;;=4^374.11
 ;;^UTILITY(U,$J,358.3,5546,2)
 ;;=Ectropion, Senile^269083
 ;;^UTILITY(U,$J,358.3,5547,0)
 ;;=333.81^^36^392^6
 ;;^UTILITY(U,$J,358.3,5547,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5547,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,5547,1,4,0)
 ;;=4^333.81
 ;;^UTILITY(U,$J,358.3,5547,2)
 ;;=Blepharospasm^15293
 ;;^UTILITY(U,$J,358.3,5548,0)
 ;;=351.8^^36^392^62
 ;;^UTILITY(U,$J,358.3,5548,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5548,1,3,0)
 ;;=3^Hemifacial Spasm
 ;;^UTILITY(U,$J,358.3,5548,1,4,0)
 ;;=4^351.8
 ;;^UTILITY(U,$J,358.3,5548,2)
 ;;=Hemifacial Spasm^87589
 ;;^UTILITY(U,$J,358.3,5549,0)
 ;;=374.10^^36^392^17
 ;;^UTILITY(U,$J,358.3,5549,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5549,1,3,0)
 ;;=3^Ectropion, Unspecified
 ;;^UTILITY(U,$J,358.3,5549,1,4,0)
 ;;=4^374.10
 ;;^UTILITY(U,$J,358.3,5549,2)
 ;;=Ectropion, Unspecified^38326
 ;;^UTILITY(U,$J,358.3,5550,0)
 ;;=374.14^^36^392^13
 ;;^UTILITY(U,$J,358.3,5550,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5550,1,3,0)
 ;;=3^Ectropion, Cicatricial
 ;;^UTILITY(U,$J,358.3,5550,1,4,0)
 ;;=4^374.14
 ;;^UTILITY(U,$J,358.3,5550,2)
 ;;=Edctropion, Cicatricial^269089
 ;;^UTILITY(U,$J,358.3,5551,0)
 ;;=374.12^^36^392^14
 ;;^UTILITY(U,$J,358.3,5551,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5551,1,3,0)
 ;;=3^Ectropion, Mechanical
 ;;^UTILITY(U,$J,358.3,5551,1,4,0)
 ;;=4^374.12
 ;;^UTILITY(U,$J,358.3,5551,2)
 ;;=Ectropion, Mechanical^269085
 ;;^UTILITY(U,$J,358.3,5552,0)
 ;;=374.13^^36^392^16
 ;;^UTILITY(U,$J,358.3,5552,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5552,1,3,0)
 ;;=3^Ectropion, Spastic
 ;;^UTILITY(U,$J,358.3,5552,1,4,0)
 ;;=4^374.13
 ;;^UTILITY(U,$J,358.3,5552,2)
 ;;=Ectropion, Spastic^269087
 ;;^UTILITY(U,$J,358.3,5553,0)
 ;;=374.00^^36^392^22
 ;;^UTILITY(U,$J,358.3,5553,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5553,1,3,0)
 ;;=3^Entropion, Unspec
 ;;^UTILITY(U,$J,358.3,5553,1,4,0)
 ;;=4^374.00
 ;;^UTILITY(U,$J,358.3,5553,2)
 ;;=Entropion, Unspec^41016
 ;;^UTILITY(U,$J,358.3,5554,0)
 ;;=374.04^^36^392^18
 ;;^UTILITY(U,$J,358.3,5554,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5554,1,3,0)
 ;;=3^Entropion, Cicatricial
 ;;^UTILITY(U,$J,358.3,5554,1,4,0)
 ;;=4^374.04
 ;;^UTILITY(U,$J,358.3,5554,2)
 ;;=Entropion, Cicatricial^269080
 ;;^UTILITY(U,$J,358.3,5555,0)
 ;;=374.02^^36^392^19
 ;;^UTILITY(U,$J,358.3,5555,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5555,1,3,0)
 ;;=3^Entropion, Mechanical
 ;;^UTILITY(U,$J,358.3,5555,1,4,0)
 ;;=4^374.02
 ;;^UTILITY(U,$J,358.3,5555,2)
 ;;=Entropion, Mechanical^269076
 ;;^UTILITY(U,$J,358.3,5556,0)
 ;;=374.03^^36^392^21
 ;;^UTILITY(U,$J,358.3,5556,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5556,1,3,0)
 ;;=3^Entropion, Spastic
 ;;^UTILITY(U,$J,358.3,5556,1,4,0)
 ;;=4^374.03
 ;;^UTILITY(U,$J,358.3,5556,2)
 ;;=Spastic Entropion^269078
 ;;^UTILITY(U,$J,358.3,5557,0)
 ;;=870.0^^36^392^58
 ;;^UTILITY(U,$J,358.3,5557,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5557,1,3,0)
 ;;=3^Eyelid/Periocular Skin Laceration
 ;;^UTILITY(U,$J,358.3,5557,1,4,0)
 ;;=4^870.0
 ;;^UTILITY(U,$J,358.3,5557,2)
 ;;=Laceration, Eyelid^274879
 ;;^UTILITY(U,$J,358.3,5558,0)
 ;;=374.20^^36^392^72
 ;;^UTILITY(U,$J,358.3,5558,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5558,1,3,0)
 ;;=3^Lagophthalmos
 ;;^UTILITY(U,$J,358.3,5558,1,4,0)
 ;;=4^374.20
 ;;^UTILITY(U,$J,358.3,5558,2)
 ;;=Lagophthalmos^265452
 ;;^UTILITY(U,$J,358.3,5559,0)
 ;;=378.9^^36^392^98
 ;;^UTILITY(U,$J,358.3,5559,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5559,1,3,0)
 ;;=3^Strabismus
 ;;^UTILITY(U,$J,358.3,5559,1,4,0)
 ;;=4^378.9
 ;;^UTILITY(U,$J,358.3,5559,2)
 ;;=Strabismus^123833
 ;;^UTILITY(U,$J,358.3,5560,0)
 ;;=242.90^^36^392^99
 ;;^UTILITY(U,$J,358.3,5560,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5560,1,3,0)
 ;;=3^Thyrotoxicosis w/o Crisis Thyroid Eye Dis
 ;;^UTILITY(U,$J,358.3,5560,1,4,0)
 ;;=4^242.90
 ;;^UTILITY(U,$J,358.3,5560,2)
 ;;=Thyroid Eye Disease^267811^376.21
 ;;^UTILITY(U,$J,358.3,5561,0)
 ;;=374.05^^36^392^100
 ;;^UTILITY(U,$J,358.3,5561,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5561,1,3,0)
 ;;=3^Trichiasis w/o Entropion
 ;;^UTILITY(U,$J,358.3,5561,1,4,0)
 ;;=4^374.05
 ;;^UTILITY(U,$J,358.3,5561,2)
 ;;=Trichiasis^269082
 ;;^UTILITY(U,$J,358.3,5562,0)
 ;;=375.21^^36^392^69
 ;;^UTILITY(U,$J,358.3,5562,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5562,1,3,0)
 ;;=3^Lacrimal,Epiphora,Excess
